The changing role of imaging in clinical care

Nat Rev Urol. 2014 Feb;11(2):75-7. doi: 10.1038/nrurol.2013.319. Epub 2014 Jan 14.


Considerable developments in prostate cancer in 2013 have emerged from the imaging field. Hyperpolarized 13C-MRI can monitor metabolic activity to identify high-grade disease and treatment response, and novel PET radiotracers might identify distinct subsets of patients with advanced disease. These examples highlight the progress made at all stages of care.

MeSH terms

  • Diagnostic Imaging*
  • Humans
  • Male
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / therapy*